CAS: 58255-18-8; N-Methyl-1-(Thiophen-2-yl)Methanamine

该化合物是一种有机化合物,其特征是存在一个三二体基的化合物,该化合物是含有硫磺的五人芳香环,该化合物的特征是附于氮原子的甲基组,使其成为第三级矿泉,其结构允许与生物系统发生潜在互动,这可能影响其药理特性.N-M乙-(2-乙基甲基)胺通常无色至黄色液体或固体,视其纯度和具体条件而定.该化合物在有机溶剂中是可溶的,反映了其非极性特性,因为二二维尼基生物功能组的存在,该化合物可能具有基本特性,使其得以参与各种化学反应,包括烷化和细胞反应,其独特的结构和特性使其对医药化学和材料科学感兴趣,尽管根据正在进行的研究与发展情况,其具体应用可能有所不同.应参考安全数据,以便处理和储存,如同所有化学物质一样.

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号98-03-3 2-噻吩甲醛 | CAS号74-89-5 氨基甲烷 | CAS号765-50-4 2-氯甲基噻吩 | CAS号54433-71-5 2-((methylimino... | CAS号39880-77-8 N-甲基-(6ci,7ci,9... | CAS号850638-58-3 1,3,5-tris-[2]t... | CAS号7647-01-0 盐酸 | CAS号70696-52-5 4-(4-bromopheny...

合成工艺路线路线简述

    📜2-氯甲基噻吩置于乙醇,甲胺体系中,化学反应生成 N-甲基-2-噻吩甲胺
    参考文献:α-Thienylaminoalkanes
    标题:α-Thienylaminoalkanes
    摘要:
    DOI:10.1021/ja01255A001

    海关参考信息

    专利信息


    专利号:US-10766863-B2
    优先权日:2014-11-17
    标 题 :Monocarboxylate transport modulators and uses thereof
    发明人:SANDANAYAKA VINCENT; WU QIONG
    权利人:NIROGYONE THERAPEUTICS INC
    摘要:The invention generally relates to the field of monocarboxylate transport modulators, e.g., monocarboxylate transport inhibitors, and more particularly to new substituted-quinolone compounds, the synthesis and use of these compounds and their pharmaceutical compositions, e.g., in treating, modulating, forestalling and/or reducing physiological conditions associated with monocarboxylate transport activity such as in treating cancer and other neoplastic disorders, inflammatory diseases, disorders of abnormal tissue growth and fibrosis including cardiomyopathy, obesity, diabetes, cardiovascular diseases, tissue and organ transplant rejection, and malaria.

    专利号:US-9701686-B2
    优先权日:2009-12-04
    标题:Tricyclopyrazole derivatives
    发明人:DISINGRINI TERESA; MANTEGANI SERGIO; VARASI MARIO
    权利人:NERVIANO MEDICAL SCIENCES SRL
    摘要:Compounds which are tricyclopyrazole derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, viral infection, prevention of AIDS development in HIV-infected individuals, cell proliferative disorders, autoimmune and neurodegenerative disorders; also disclosed is a process under Solid Phase Synthesis conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.

    专利号:CN-118561738-A
    优先权日:2024-05-09
    标题 :Synthesis method of 3-indolone

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知